These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2408246)

  • 1. [ACE inhibitors and kidney].
    Ritz E
    Wien Med Wochenschr; 1990 Jan; 140(1-2):18-21. PubMed ID: 2408246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACE inhibition and renal protection.
    Ritz E
    Clin Physiol Biochem; 1992; 9(3):94-7. PubMed ID: 1302163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Progression of chronic renal insufficiency and its prevention using angiotensin converting enzyme inhibitors and angiotensin antagonists].
    Tesar V
    Vnitr Lek; 2003 May; 49(5):365-9. PubMed ID: 12908169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nephroprotection by inhibition of the renin-angiotensin system--wish or reality?].
    Barnas U; Mayer G
    Wien Klin Wochenschr; 1995; 107(1):10-4. PubMed ID: 7871784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The ACE inhibitor spirapril in chronic renal failure, hypertension and diabetic nephropathy].
    Elliot HL
    Ter Arkh; 2000; 72(10):78-82. PubMed ID: 11220886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [ACE inhibitors--a potential new group of drugs for treatment of kidney diseases].
    Podracká L; Sasinka M; Böör A
    Cesk Pediatr; 1993 Jan; 48(1):29-31. PubMed ID: 8477465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [ACE inhibitors--a prospective new group of drugs for the treatment of kidney diseases].
    Podracká L; Sasinka M; Böör A
    Cesk Pediatr; 1992 Dec; 47(12):730-2. PubMed ID: 1294314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACE-inhibitors and progression of chronic renal insufficiency: a contribution of Italian clinical research.
    Andreucci VE; Gallieni M; Brancaccio D
    J Nephrol; 1998; 11(3):105-9. PubMed ID: 9650118
    [No Abstract]   [Full Text] [Related]  

  • 10. ACE inhibitors as a shield against diabetic nephropathy.
    Materson BJ
    Arch Intern Med; 1996 Feb; 156(3):239-40. PubMed ID: 8572832
    [No Abstract]   [Full Text] [Related]  

  • 11. [Angiotensin I converting enzyme inhibitor enalapril in treatment of progressive chronic nephropathy. An open randomized controlled trial].
    Kamper AL; Strandgaard S; Leyssac PP
    Ugeskr Laeger; 1993 Aug; 155(31):2406-9. PubMed ID: 8346593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACE inhibitors and renoprotection.
    Peterson K
    J Fam Pract; 1996 May; 42(5):453. PubMed ID: 8642355
    [No Abstract]   [Full Text] [Related]  

  • 13. Toward better renoprotection: lessons from angiotensin receptor blockers.
    Miyata T; Takizawa S
    Hemodial Int; 2007 Apr; 11(2):164-8. PubMed ID: 17403166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trials in progression of chronic renal failure.
    Striker GE; Klahr S
    Adv Intern Med; 1997; 42():555-95. PubMed ID: 9048130
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic effects of angiotensin II inhibition or blockade on the progression of chronic renal disease.
    Cantarovich F; Rangoonwala B
    Int J Clin Pract; 2003 Nov; 57(9):801-22. PubMed ID: 14686572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ace inhibition in renal disease: risks and benefits.
    Campanacci L; Fabris B; Fischetti F; Bardelli M; Vran F; Carretta R
    Clin Exp Hypertens; 1993; 15 Suppl 1():173-86. PubMed ID: 8513308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibitor for slowing progression of diabetic and nondiabetic kidney disease.
    Myers BD; Boothroyd D; Olshen RA
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S66-70. PubMed ID: 11443771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical use of angiotensin-converting enzyme inhibitors in patients with renal impairment.
    Elliott HL
    Blood Press Suppl; 1994; 2():31-4. PubMed ID: 8061843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [ACE inhibitors and AT-II antagonists--do they protect against renal disease?].
    Rossing P; Parving HH
    Ugeskr Laeger; 2006 Apr; 168(15):1564; author reply1564-5. PubMed ID: 16640990
    [No Abstract]   [Full Text] [Related]  

  • 20. [ACE inhibitors and the kidney].
    Hörl WH
    Wien Med Wochenschr; 1996; 146(11):231-4; discussion 234-5. PubMed ID: 8928521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.